169 related articles for article (PubMed ID: 15920997)
1. Treprostinil for the treatment of severe digital necrosis in systemic sclerosis.
Engel G; Rockson SG
Vasc Med; 2005 Feb; 10(1):29-32. PubMed ID: 15920997
[TBL] [Abstract][Full Text] [Related]
2. Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1).
Mecoli CA; Perin J; Van Eyk JE; Zhu J; Fu Q; Allmon AG; Rao Y; Zeger S; Wigley FM; Hummers LK; Shah AA
Clin Rheumatol; 2020 Apr; 39(4):1199-1205. PubMed ID: 31858338
[TBL] [Abstract][Full Text] [Related]
3. The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil.
Shah AA; Schiopu E; Chatterjee S; Csuka ME; Frech T; Goldberg A; Spiera R; Peng SL; McBride RJ; Cleveland JM; Steen V
J Rheumatol; 2016 Sep; 43(9):1665-71. PubMed ID: 27307535
[TBL] [Abstract][Full Text] [Related]
4. A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis.
Chung L; Fiorentino D
J Am Acad Dermatol; 2006 May; 54(5):880-2. PubMed ID: 16635673
[TBL] [Abstract][Full Text] [Related]
5. Treprostinil Hydrogel Iontophoresis in Systemic Sclerosis-Related Digital Skin Ulcers: A Safety Study.
Guigui A; Mazet R; Blaise S; Cracowski C; Beau-Guillaumot M; Kotzki S; Roustit M; Cracowski JL
J Clin Pharmacol; 2020 Jun; 60(6):758-767. PubMed ID: 32080862
[TBL] [Abstract][Full Text] [Related]
6. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
Oudiz RJ; Schilz RJ; Barst RJ; Galié N; Rich S; Rubin LJ; Simonneau G;
Chest; 2004 Aug; 126(2):420-7. PubMed ID: 15302727
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous iontophoresis of treprostinil in systemic sclerosis: a proof-of-concept study.
Roustit M; Gaillard-Bigot F; Blaise S; Stanke-Labesque F; Cracowski C; Seinturier C; Jourdil JF; Imbert B; Carpentier PH; Cracowski JL
Clin Pharmacol Ther; 2014 Apr; 95(4):439-45. PubMed ID: 24458011
[TBL] [Abstract][Full Text] [Related]
8. Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion.
Shah AA; Schiopu E; Hummers LK; Wade M; Phillips K; Anderson C; Wise R; Boin F; Seibold JR; Wigley F; Rollins KD
Arthritis Res Ther; 2013 Apr; 15(2):R54. PubMed ID: 23597147
[TBL] [Abstract][Full Text] [Related]
9. [A case of systemic sclerosis in childhood complicated by severe digital ulcers].
Falcini F; Volpi M; Pierattelli M; Taccetti G; Pratesi G; Matucci Cerinich M
Pediatr Med Chir; 1984; 6(5):703-7. PubMed ID: 6535137
[TBL] [Abstract][Full Text] [Related]
10. Bosentan is effective against digital ulcerations and hyperkeratosis in systemic sclerosis.
Kurgyis Z; Varga R; Sick I; Lang MU; Ruzicka T; Sárdy M
Acta Derm Venereol; 2011 Oct; 91(6):716-7. PubMed ID: 21879251
[No Abstract] [Full Text] [Related]
11. Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.
Rademaker M; Thomas RH; Provost G; Beacham JA; Cooke ED; Kirby JD
Postgrad Med J; 1987 Aug; 63(742):617-20. PubMed ID: 2447572
[TBL] [Abstract][Full Text] [Related]
12. Treprostinil for the treatment of pulmonary arterial hypertension.
Torres F; Rubin LJ
Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):13-25. PubMed ID: 23259441
[TBL] [Abstract][Full Text] [Related]
13. [Digital ulcers in systemic scleroderma].
Lok C; Mouthon L; Ségard M; Richard MA; Guillevin L
Ann Dermatol Venereol; 2011 Nov; 138(11):762-8; quiz 761, 769. PubMed ID: 22078040
[No Abstract] [Full Text] [Related]
14. Treatment of complications associated with systemic sclerosis.
Moore SC; Desantis ER
Am J Health Syst Pharm; 2008 Feb; 65(4):315-21. PubMed ID: 18238768
[TBL] [Abstract][Full Text] [Related]
15. Raynaud phenomenon and digital ulcers in systemic sclerosis.
Hughes M; Allanore Y; Chung L; Pauling JD; Denton CP; Matucci-Cerinic M
Nat Rev Rheumatol; 2020 Apr; 16(4):208-221. PubMed ID: 32099191
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis: bilateral improvement of Raynaud's phenomenon with unilateral digital sympathectomy.
Wasserman A; Brahn E
Semin Arthritis Rheum; 2010 Oct; 40(2):137-46. PubMed ID: 19878974
[TBL] [Abstract][Full Text] [Related]
17. [Hand involvement in systemic sclerosis].
Mouthon L
Presse Med; 2013 Dec; 42(12):1616-26. PubMed ID: 24268960
[TBL] [Abstract][Full Text] [Related]
18. Treprostinil sodium (Remodulin), a prostacyclin analog, in the treatment of critical limb ischemia: open-label study.
Berman S; Quick R; Yoder P; Voigt S; Strootman D; Wade M
Vascular; 2006; 14(3):142-8. PubMed ID: 16956486
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of Raynaud's phenomenon in scleroderma with a new stable prostacyclin derivative].
Keller J; Kaltenecker A; Schricker KT; Krais T; Schönberger A; Gevatter M; Hornstein OP
Dtsch Med Wochenschr; 1984 Sep; 109(38):1433-8. PubMed ID: 6383760
[TBL] [Abstract][Full Text] [Related]
20. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
Gore J; Silver R
Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
[No Abstract] [Full Text] [Related]
[Next] [New Search]
